06 Jun 2022 Policy
An open letter to people with a weakened immune system
Leukaemia UK joins the NHS and other charity leaders by signing an open letter, to encourage people with a weakened immune system to continue to book in or visit a walk-in centre for their Covid-19 vaccines.
The Joint Committee on Vaccination and Immunisation (JCVI) advises all individuals aged 12 years and over who are immunosuppressed should receive a Spring booster dose of the vaccine.
If you are immunosuppressed, either due to a health condition or medical treatment, you may not yet have the best protection you can possibly get from the vaccine.
You should usually be contacted by the NHS when you are due a Spring booster. Please do take up this offer. If you haven’t heard and you think you may be eligible then you can book a vaccination or find a convenient local walk-in site.
The JCVI recommends that people with a weakened immune system receive their Spring booster as close as possible to six months after their last dose for maximum protection. However, the booster can be given from three months where necessary, depending on individual circumstances.
The NHS has made some changes which means it has never been easier to get your booster if you are immunosuppressed. After booking, you can bring one of several documents to the appointment to confirm you are eligible. This should be one of the following:
- A letter from your GP or specialist advising you get the jab
- A hospital letter about your condition or medication
- A prescription or medication box with your name and a date on it
If you don’t have any of this evidence to hand, don’t worry. It may still be possible to get vaccinated, just speak to a clinician when you arrive for your appointment.
Vaccination appointments can be booked quickly and conveniently by visiting www.nhs.uk/covid-vaccination, where you can also find out which vaccines you are eligible for.
There are three ways you can access your vaccination:
- Make an appointment through the national booking service
- Call 119 to book an appointment (calls are free and translators are available on request)
- Find a walk-in site (not every walk-in site is able to offer vaccination for people who are immunosuppressed, so please use the NHS’ online finder to make sure you choose the right site for you)
Whether one of your vaccines is overdue or you haven’t had your first yet, please be assured that it isn’t too late.
Please let the NHS know if you have any difficulty accessing your vaccination so that the issue can be resolved and services can be improved.
There are a number of ways you can contact NHS England. Information about how to get in touch is available here on their website.
Fiona Hazell, CEO, Leukaemia UK
Professor Stephen Powis, National Medical Director, NHS England and NHS Improvement
Steve Russell, National Director for Vaccinations and Screening, NHS England and NHS Improvement
Dr Nikita Kanani MBE, Deputy Senior Responsible Officer, NHS Vaccine Deployment, and Medical Director for Primary Care, NHS England and NHS Improvement
Dr Jonathan Leach OBE, Medical Director for COVID-19 Vaccination, NHS England and NHS Improvement
Dr Bola Owolabi, Director, Healthcare Inequalities, NHS England and NHS Improvement
Henny Braund MBE, CEO, Anthony Nolan
Gemma Peters, CEO, Blood Cancer UK
Genevieve Edwards, CEO, Bowel Cancer UK
William Jones, CEO, Brainstrust
Alex Lochrane, CEO, The Brain Tumour Charity
Baroness Delyth Morgan, CEO, Breast Cancer Now
Mr Sharif Kaf Al-Ghazal, President, British Islamic Medical Association
Pamela Healy OBE, CEO, British Liver Trust
Matthew Patey OBE, CEO, British Skin Foundation
Dr Sanjeev Patel, President, British Society for Rheumatology
Professor Frank Chinegwundoh MBE, Chair, Cancer Black Care
Ian Walker, Executive Director of Policy, Information and Communications, Cancer Research UK
Jane Lyons, CEO, Cancer52
Rev Charles Kwaku-Odoi, Chief Officer, Caribbean and African Health Network
Eddie Chan, Co-Chair, Chinese Welfare Trust
Sarah Sleet, CEO, Crohn’s and Colitis UK
Louise Ansari, National Director, Healthwatch England
Umesh Sharma, Chair, Hindu Council UK
Samantha Dixon, CEO, Jo’s Cervical Cancer Trust
Nick Turkentine, CEO, Kidney Cancer UK
Paul Bristow, CEO, Kidney Care UK
Zack Pemberton-Whiteley, CEO, Leukaemia Care
Paul Howard, CEO, LUPUS UK
Dr Anthony Cunliffe, National Clinical Advisor Primary Care, Macmillan Cancer Support
Nick Moberly, CEO, MS Society
Sophie Castell, CEO, Myeloma UK
Deborah Gold, CEO, National AIDS Trust
Dr Charlotte Augst, CEO, National Voices
Ali Stunt, CEO, Pancreatic Cancer Action
Diana Jupp, CEO, Pancreatic Cancer UK
Laura Kerby, CEO, Prostate Cancer UK
Helen McAteer, CEO, The Psoriasis Association
Richard Davidson, CEO, Sarcoma UK
Sue Farrington, CEO, Scleroderma and Raynaud’s UK
Emma Willis, Co-CEO, Shine Cancer Support
Kirit Mistry, Chair, South Asian Health Action
Dr Binita Kane, Co-Founder, South Asian Heritage Month
Annwen Jones OBE, CEO, Target Ovarian Cancer
Kate Collins, CEO, Teenage Cancer Trust
Ian Green, CEO, Terrence Higgins Trust
Deborah Alsina MBE, CEO, Versus Arthritis
Related posts
19 February 2024
Leukaemia UK launches new Patient Care Pioneer Award funding initiative
Leukaemia UK is delighted to launch a brand-new funding scheme in 2024, intended specifically for innovative, patient-focussed applied research and targeting UK-based healthcare professionals. The first of its kind for…
3 February 2023
Team Bodhi goes viral with #PantsToLeukaemia campaign
A whole host of celebrities and members of the public are posing with their pants on their head for a new campaign, to show solidarity for a little boy with…
15 June 2018
MP opens Leukaemia UK Ambulatory Care Unit
A unit funded by Leukaemia UK which allows people with blood cancer to have stem cell transplants as out-patients has been officially opened by its first patient, Nick Boles MP
12 December 2022
Widespread coverage of new leukaemia therapy shows promise in first trial patient
As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…